Form 8-K - Current report:
SEC Accession No. 0001493152-24-032218
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:21
Documents
29
Period of Report
2024-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50353
2 ex10-1.htm EX-10.1 375924
3 ex10-2.htm EX-10.2 10651
4 ex99-1.htm EX-99.1 14146
5 ex10-1_001.jpg GRAPHIC 74451
6 ex10-1_002.jpg GRAPHIC 15351
7 ex10-2_001.jpg GRAPHIC 384722
8 ex10-2_002.jpg GRAPHIC 641699
9 ex10-2_003.jpg GRAPHIC 501202
10 ex10-2_004.jpg GRAPHIC 619642
11 ex10-2_005.jpg GRAPHIC 528476
12 ex10-2_006.jpg GRAPHIC 537878
13 ex10-2_007.jpg GRAPHIC 563665
14 ex10-2_008.jpg GRAPHIC 530410
15 ex10-2_009.jpg GRAPHIC 381962
16 ex10-2_010.jpg GRAPHIC 440779
  Complete submission text file 0001493152-24-032218.txt   7855416

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE shph-20240808.xsd EX-101.SCH 3030
18 XBRL LABEL FILE shph-20240808_lab.xml EX-101.LAB 34240
19 XBRL PRESENTATION FILE shph-20240808_pre.xml EX-101.PRE 22369
32 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 241208021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)